CVKD vs EXC · $20.2M cap vs P/E 17, rev $24.26B
Cadrenal Therapeutics, Inc. Common Stock (CVKD) versus Exelon Corporation (EXC) — a side-by-side from cached financials, not a winner call.
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a biotechnology company listed on US.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
CVKD does not have a complete income-statement cache yet.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
CVKD currently screens at market cap $20.2M. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Not investment advice. Open the CVKD and EXC stock pages for the full models.
Not investment advice.